
AZD-0837 is a novel oral anticoagulant that after bioconversion to its active form is a мощный and reversible thrombin ингибитор, has been investigated in phase II studies for prevention of stroke and systemic embolic events in patients with atrial fibril
AZD-0837 is a novel oral anticoagulant that after bioconversion to its active form is a potent and reversible thrombin inhibitor, has been investigated in phase II studies for prevention of stroke and systemic embolic events in patients with atrial fibril
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.